FIRMQUARRYResearch workspace

EU_TED process · buyer country DNK · award

Rammeaftale om køb af Susvimo (ranibizumab)

['Amgros I/S']

Procedure 0796f5d2-7354-4c8b-9c0e-4e3a0b26c25dCPV 33600000Healthcare
Not reported
Data last updated Oct 22, 2026 · Source: Tenders Electronic Daily
Buyer identifier
TED_ORGANISATION: 14479880
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
Not reported
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Susvimo (ranibizumab). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    Rammeaftale om køb af Susvimo (ranibizumab)

    DNK · eu_tedSource ↗

Notice versions

PublicationVersionTypeDateSource
762563-20261veatNov 3, 2026Official notice ↗ · XML ↗

Lots

LotCPVPerformanceNUTSValue
LOT-000133600000, 33600000DNKDK011Not reported

Contracts

ContractLotStatusPeriodValue
Rammeaftale om køb af Susvimo (ranibizumab)LOT-0001Not reportedNot reported — Not reportedNot reported

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched
4e18f4a2-e253-47cb-9d0a-8fd739ba1bab:1Nov 3, 2026award_announcedNov 3, 2026